Archit Sheth-Shah Email & Phone Number

New York, NY, US

• Consultant & investor working with a select group of investment funds and high-growth biotech / techbio companies. Completed projects include:
• Created market model, scenario planned across clinical development strategies, and benchmarked competitors to support Schrödinger’s decision-making and future capital allocation for internal therapeutic program.
• Sourced and evaluated growth-stage healthcare investments as an Entrepreneur-in-Residence at Anthos Capital. Developed firm's thesis on Artificial Intelligence in Healthcare.
• Conducted a market + landscape analysis on pancreatic islet cell implants for T1D patients for a biotech venture fund.
• Developed a go-to-market strategy and identified 200+ potential leads for Inductive Bio's ML-based computational chemistry platform.
• Developed operating model, critical investor materials, and prioritized potential BD opportunities for Waypoint Bio, a platform for the design, testing, and optimization of solid tumor cell therapies.

Menlo Park, CA, US

• Founding team member and first business hire for Series A single-cell spatial proteomics data generation and analysis startup.A few highlights:
• Identified, sourced, and closed >30 collaborations with researchers from major global academic medical centers (e.g., Carnegie Mellon, Dana-Farber Cancer Institute, Mayo Clinic, Stanford, UC San Francisco, University.
• Co-led fundraising process for Enable's $60M Series A, led by Anthos Capital with participation from General Catalyst and other top VC firms. Developed materials (story, investment memo, pitch deck, op model) and led.
• Recruited >50% of ~30-person team (as of 9/2022) across computational biology, lab operations, talent acquisition, and business operations. Implemented applicant tracking system, served as interim recruiting and.
• Recruited some incredible scientific and business advisors, including Dr. Jim Allison, Dr. Padmanee Sharma, Dr. Andrew Lo, and Dr. Tom Bumol. Worked with advisory board on various internal projects.
• Negotiated and closed preferred pricing agreements with critical suppliers, generating 30-70% savings for inputs to Enable's data generation and analysis platform.

New York, New York, US

• Worked directly with Chief Investment Officer on all stages of therapy in-licensing and company creation, including scientific and commercial diligence, deal construction, follow-on capital allocation, and Roivant and.
• Acquisition of Oncopia Therapeutics and creation of Roivant's Targeted Protein Degradation Platform
• Acquisition of namilumab (anti-GM-CSF) for development in pulmonary sarcoidosis

New York, New York, US

• Served as advisor to President of Roivant Pharma (~75-person business unit responsible for creation and ongoing governance of 15 subsidiaries, or "Vants"). Helped set organizational strategy and goals, worked on all.
• $3B Strategic Alliance with Dainippon Sumitomo Pharma

London, Greater London, GB

Hired by CFO of robo-advisory start-up to build investment presentation for Series B fundraise. Developed expansion strategy, conducted competitive benchmarking, evaluated potential acquisitions, and helped craft investor list.

San Francisco, California, US

Led/assisted across all stages of early-stage venture process, including sourcing and diligencing Seed/A investments and working sessions with portfolio CEOs. Developed firm’s viewpoints on Data in Healthcare and on Clinical Trial Technology.

Boston, MA, US

Consulted pro-bono to Ministries of Health and Expanded Programs on Immunization in Uganda, Nigeria, Ethiopia, Kenya, Cameroon, and Lesotho. Developed scaling framework for use of Remote Temperature Monitoring Devices (RTMDs) in vaccine cold chains and worked with CHAI country teams and government officials to pilot and scale RTMD use. Created Zika vaccine.

Boston, MA, US

• Management consulting work across Healthcare, Technology, Financial Services, Consumer Products, and Private Equity sectors. Drove key insights for clients in both Asia and the U.S., including:
• Led resource allocation strategy for global pharmaceutical firm’s Malaysia division, retrospectively analyzing spend on field force, medical activities, and other OpEx to determine highest-value product-specific.
• Identified highest-priority populations and built revenue forecasting model for new product launch that identified >$600M in potential U.S. revenue. Communicated findings with senior stakeholders of global pharma firm.
• Led integration value analysis for 14-product enterprise software portfolio to determine top product integration opportunities and helped develop cross-functional organizational structure to enable integrations.In.

Boston, MA, US

Worked on four due diligences within the private equity group spanning a number of sectors. Assisted in primary and secondary research. Owned portions of workstreams throughout 10-week internship. Worked on a pro-bono case for Breakthrough Collaborative through the Inspire program.

Redwood City, CA, US

Assisted in a number of laboratory procedures for various R&D projects; worked closely with Chief Scientific Officer in researching and developing procedures to test the importance of a superfamily of genes in breast & prostate cancer.

Master Of Science - Ms, Bioengineering

Master Of Business Administration (Mba)

Bachelor Of Science - Bs, Biomedical Engineering; Economics